Goldenseal, a plant-based supplement, may help lower 'bad' cholesterol in animals and lab tests by telling the liver to pull more cholesterol out of the blood.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The claim is based on experimental models (likely animal or in vitro studies), which can demonstrate mechanistic pathways like receptor upregulation and LDL-c reduction. However, these findings do not confirm efficacy or safety in humans. The use of 'is identified as' implies a level of established fact that exceeds current evidence, which is limited to preclinical data. A more cautious verb like 'may' or 'appears to' better reflects the evidence level.
More Accurate Statement
“Goldenseal may lower low-density lipoprotein cholesterol (LDL-c) in experimental models by upregulating hepatic LDL receptor expression.”
Context Details
Domain
medicine
Population
animal
Subject
Goldenseal
Action
is identified as a natural LDL-c-lowering agent based on its ability to upregulate hepatic LDL receptor expression and reduce plasma LDL-c
Target
hepatic LDL receptor expression and plasma LDL-c levels
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Scientists found that goldenseal, a plant used in medicine, lowers bad cholesterol in lab cells and hamsters by helping the liver remove more cholesterol from the blood. This matches what the claim says.